Squarepoint Ops LLC Tyme Technologies, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$1.14 - $1.87 $15,668 - $25,701
-13,744 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.34 - $3.53 $18,416 - $48,516
13,744 New
13,744 $24,000
Q3 2020

Nov 16, 2020
SELL
$0.93 - $1.35 $52,526 - $76,248
-56,480 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.97 - $1.7 $54,785 - $96,016
56,480 New
56,480 $75,000
Q1 2020

May 15, 2020
SELL
$0.9 - $1.95 $22,856 - $49,522
-25,396 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$1.0 - $1.49 $34,022 - $50,692
-34,022 Reduced 57.26%
25,396 $36,000
Q3 2019

Nov 14, 2019
BUY
$0.97 - $1.77 $57,635 - $105,169
59,418 New
59,418 $71,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email